Skip to main content

Table 2 Details of intra- and post-operative events and outcomes. Data are shown as median (25%; 75%) quartiles or as n (%) patients

From: The need for post-operative vasopressor infusions after major gynae-oncologic surgery within an ERAS (Enhanced Recovery After Surgery) pathway

Intra-operative; number of patients = 324

 Estimated Blood Loss (ml)

800 (321–1400)

 Total volume of IV fluid (ml)

2500 (1500–3500)

 Transfused (n, %)

34 (11%)

Post-operative; number of patients = 324

 Cumulative fluid balance (l)

2.8 (1.6–4.7)

 Epidural use

229 (70.67%)

 Received any post-operative vasopressor infusion PVI, n (%)

161 (50%)

 Met criteria for vasoplegia, n (%)

61 (19%)

 Peak lactate in first 24 h, mmol/l

2.0 (1.4–2.9)

 APACHE II score (points)

12 (9–15)

 ICU LOS (days)

2 (1–3)

 Hospital LOS (days)

5 (4–7)

 Mortality at 28 days (%)

5 (1.54%)